Stéphane Chèze

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

Sophie Park, Sophie Grabar, Charikleia Kelaïdi et al. · Blood · 2007 · 330 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

Bertrand Godeau, Sylvie Chevret, Bruno Varet et al. · The Lancet · 2002 · 265 citations

Life Sciences, Hematology, Immunology +12

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

Bertrand Godeau, Raphaël Porcher, Olivier Fain et al. · Blood · 2008 · 243 citations · Full text

Life Sciences, Hematology, Immunology +8

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

Frédérik Damm, Virginie Chesnais, Yasunobu Nagata et al. · Blood · 2013 · 227 citations

Medicine, Genetics, Molecular Genetics +8

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

Christian Rosé, Sabine Bréchignac, D. Vassilief et al. · Leukemia Research · 2010 · 195 citations

Medicine, Hematology, Pharmacotherapy +11